Literature DB >> 11201745

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

L S Michel1, V Liberal, A Chatterjee, R Kirchwegger, B Pasche, W Gerald, M Dobles, P K Sorger, V V Murty, R Benezra.   

Abstract

The mitotic checkpoint protein hsMad2 is required to arrest cells in mitosis when chromosomes are unattached to the mitotic spindle. The presence of a single, lagging chromosome is sufficient to activate the checkpoint, producing a delay at the metaphase-anaphase transition until the last spindle attachment is made. Complete loss of the mitotic checkpoint results in embryonic lethality owing to chromosome mis-segregation in various organisms. Whether partial loss of checkpoint control leads to more subtle rates of chromosome instability compatible with cell viability remains unknown. Here we report that deletion of one MAD2 allele results in a defective mitotic checkpoint in both human cancer cells and murine primary embryonic fibroblasts. Checkpoint-defective cells show premature sister-chromatid separation in the presence of spindle inhibitors and an elevated rate of chromosome mis-segregation events in the absence of these agents. Furthermore, Mad2+/- mice develop lung tumours at high rates after long latencies, implicating defects in the mitotic checkpoint in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11201745     DOI: 10.1038/35053094

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  277 in total

1.  Mad2 binding to Mad1 and Cdc20, rather than oligomerization, is required for the spindle checkpoint.

Authors:  L Sironi; M Melixetian; M Faretta; E Prosperini; K Helin; A Musacchio
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex.

Authors:  Guowei Fang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

3.  Crystal structure of the tetrameric Mad1-Mad2 core complex: implications of a 'safety belt' binding mechanism for the spindle checkpoint.

Authors:  Lucia Sironi; Marina Mapelli; Stefan Knapp; Anna De Antoni; Kuan-Teh Jeang; Andrea Musacchio
Journal:  EMBO J       Date:  2002-05-15       Impact factor: 11.598

4.  Identification of a MAD2-binding protein, CMT2, and its role in mitosis.

Authors:  Toshiyuki Habu; Sang Hoon Kim; Jasminder Weinstein; Tomohiro Matsumoto
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

5.  MTBP plays a crucial role in mitotic progression and chromosome segregation.

Authors:  N Agarwal; Y Tochigi; A S Adhikari; S Cui; Y Cui; T Iwakuma
Journal:  Cell Death Differ       Date:  2011-01-28       Impact factor: 15.828

6.  G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Authors:  April L Blajeski; Vy A Phan; Timothy J Kottke; Scott H Kaufmann
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells.

Authors:  Takashi Yoshihara; Mari Ishida; Aiko Kinomura; Mari Katsura; Takanori Tsuruga; Satoshi Tashiro; Toshimasa Asahara; Kiyoshi Miyagawa
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

8.  Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1.

Authors:  Marina Cotsiki; Rowena L Lock; Yuan Cheng; Grace L Williams; Jean Zhao; David Perera; Raimundo Freire; Alan Entwistle; Erica A Golemis; Thomas M Roberts; Parmjit S Jat; Ole V Gjoerup
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

Review 9.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

10.  Mad2 and p53 expression profiles in colorectal cancer and its clinical significance.

Authors:  Gang-Qiang Li; Hao Li; Hong-Fu Zhang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.